Management to host investor conference call today, March 9, at 8:30am ET TEL AVIV, Israel, March 09, 2021 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced […]
Other News
Corindus Named to Fast Company’s “Most Innovative” List for 2021 Amid Global Expansion
Award recognition coincides with new global installations of CorPath® GRX and U.S. launch of technIQ™ WALTHAM, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, […]
CARMAT Obtains a €1.4 Million Grant as Part of the “Industrial Recovery Plan – Strategic Sectors” Call for Projects
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces that is has obtained a €1.4 million grant as […]
Stereotaxis to Establish Global Headquarters in Downtown St. Louis Globe Building
ST. LOUIS, March 08, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it will move its global headquarters to the Globe Building in downtown St. Louis at the end of this year. “Establishing our new headquarters at the Globe is […]
Zynex Announces Share Buyback Program
ENGLEWOOD, Colo., March 8, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that its board of directors approved a program to buy back $10.0 million of the Company’s common stock. The […]
Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms DUBLIN, March 4, 2021 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the first procedures in the investigational device exemption (IDE) pivotal trial to evaluate the PulseSelect™ Pulsed Field Ablation (PFA) System, a […]
MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions
NYON, Switzerland, March 4, 2021 /PRNewswire/ — MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the treatment of atherosclerotic lesions […]
Marizyme Announces New Distribution and Channel Partnership for Chilean Market with Abdera
JUPITER, Fla., March 4, 2021 /PRNewswire/ — Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has entered into a supply and distribution agreement with Abdera Financial, Inc., a Chilean based distributor, […]
EchoNous Launches Continuous and Pulsed Wave Doppler on Kosmos Hand-Carried Hardware
Kosmos now offers first-of-its-kind “Hybrid HCU” device with unprecedented imaging and functionality aimed at workflow and patient care gains REDMOND, Wash., March 4, 2021 /PRNewswire/ — EchoNous, the leading developers of AI-driven, hand-carried ultrasound, today announced the addition of both continuous wave (CW) and pulsed wave (PW) Doppler capabilities to the Kosmos hardware […]
ControlRad® Announces FDA Clearance for ControlRad Select
ATLANTA, March 4, 2021 /PRNewswire/ — ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, has announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to market ControlRad Select. The technology utilizes proprietary semi-transparent filters, a user-interface tablet, and image processing algorithms, […]
Recent
Nyra Medical Receives Prestigious Jon DeHaan Foundation Award for Innovation in Cardiology at EuroPCR 2026
AHN’s Allegheny General Hospital Unveils New, State-of-the-Art Cardiac Cath and Electrophysiology Labs, following Completion of $19 Million Renovation Project
egnite Expands Medical Advisory Board with Three Nationally Recognized Cardiovascular Specialists
Popular
- No commented posts yet